ClinicalTrials.Veeva

Menu

Construction of a Database for TTP

S

Soochow University

Status

Enrolling

Conditions

TTP - Thrombotic Thrombocytopenic Purpura

Treatments

Other: collection data

Study type

Observational

Funder types

Other

Identifiers

NCT05571774
SOOCHOW-HY-2022-12

Details and patient eligibility

About

Information about patients was collected by reviewing the Hitech case system and telephone and outpatient follow-up, and the case database was constructed by Epidata software. The sample size is expected to be 200 cases, the participating hospital is the First Affiliated Hospital of Soochow University, and the study time frame is from Oct 20, 2022, to Oct 20, 2027. The observation indexes of the study include the basic information of patients' age and gender and the clinical related data of thrombotic thrombocytopenic purpura.

Enrollment

500 estimated patients

Sex

All

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Subjects diagnosed with severe ADAMTS13 deficiency, defined as ADAMTS13 activity <10%, documented in the patient's medical history or at screening.

Exclusion criteria

  • The investigator considers the subject unable or unwilling to cooperate with the study procedures.

Trial design

500 participants in 1 patient group

TTP
Description:
TTP patients
Treatment:
Other: collection data

Trial contacts and locations

1

Loading...

Central trial contact

Yue Han, Ph.D

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems